Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 336INDUSTRY 101NIH 50OTHER_GOV 9NETWORK 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Lymphoid 66Breast 65Other hematologic neoplasm 59Genitourinary 58CNS 52Gastrointestinal 51Thoracic 40Sarcoma 29Plasma cell 28Gynecologic 22Head & Neck 19Dermatologic 18Tumor-Agnostic 15Other solid neoplasm 12Myeloid 11Endocrine 4Other neoplasm 3Classical hematology 3Other 2NET 2

Conditions

Somatostatinoma 2Neuroendocrine Tumors 2Pheochromocytoma 1Nephroma, Mesoblastic 1Neoplasms 1Myeloproliferative Disorders 1Melanoma 1Lymphoproliferative Disorders 1Insulinoma 1Glucagonoma 1Gastrinoma 1Ganglioneuroma 1Desmoid Tumors 1Central Nervous System Neoplasms 1Carcinoma, Neuroendocrine 1Carcinoma, Islet Cell 1Carcinoma in Situ 1Adenoma, Islet Cell 1

Interventions

Temozolomide 2Capecitabine 2Etoposide 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
NETWORK × Endocrine × 1 year × Clear all
NCT02402244 2026-05-05

Project: Every Child for Younger Patients With Cancer

Children's Oncology Group

Recruiting
75,000 enrolled
CNSDermatologicEndocrineLymphoidMyeloidNETSarcoma

Carcinoma in Situ, Ganglioneuroma, Lymphoproliferative Disorders, Melanoma, Myeloproliferative Disorders, Neoplasms, Pheochromocytoma, Central Nervous System Neoplasms, Nephroma, Mesoblastic, Desmoid Tumors, Neuroendocrine Tumors

NCT02595424 2026-05-01

Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas

Eastern Cooperative Oncology Group

Phase 2 Active not recruiting
67 enrolled 13 charts
Endocrine

Somatostatinoma, Carcinoma, Neuroendocrine

NCT01824875 2026-02-25

Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors

Eastern Cooperative Oncology Group

Phase 2 Active not recruiting
144 enrolled 15 charts
Endocrine

Glucagonoma, Insulinoma, Adenoma, Islet Cell, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell

NCT06345079 2025-08-14

STOPNET

Australasian Gastro-Intestinal Trials Group

Phase 2 Recruiting
78 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡